Duo Xu

936 total citations
44 papers, 691 citations indexed

About

Duo Xu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Duo Xu has authored 44 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Duo Xu's work include Occupational and environmental lung diseases (10 papers), Autophagy in Disease and Therapy (5 papers) and Ferroptosis and cancer prognosis (4 papers). Duo Xu is often cited by papers focused on Occupational and environmental lung diseases (10 papers), Autophagy in Disease and Therapy (5 papers) and Ferroptosis and cancer prognosis (4 papers). Duo Xu collaborates with scholars based in China, Switzerland and United States. Duo Xu's co-authors include Ren‐Wang Peng, Ralph A. Schmid, Haitang Yang, Thomas M. Marti, Shun‐Qing Liang, Yang Zhang, Gregor J. Kocher, Edward B. Ziff, David S. Tukey and Thomas J. J. Blanck and has published in prestigious journals such as NeuroImage, Analytical Chemistry and Cancer Research.

In The Last Decade

Duo Xu

40 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Duo Xu China 15 258 211 132 92 74 44 691
Wei Sha United States 16 235 0.9× 93 0.4× 79 0.6× 74 0.8× 58 0.8× 48 837
Mieke Verslegers Belgium 15 280 1.1× 172 0.8× 72 0.5× 107 1.2× 135 1.8× 34 800
Qiqi Xie China 15 360 1.4× 140 0.7× 100 0.8× 57 0.6× 183 2.5× 56 739
Lesley Castillo Australia 14 402 1.6× 185 0.9× 208 1.6× 172 1.9× 242 3.3× 18 948
Sonja Kallendrusch Germany 16 241 0.9× 64 0.3× 131 1.0× 83 0.9× 83 1.1× 29 609
Silvia Vanni Italy 15 210 0.8× 154 0.7× 105 0.8× 110 1.2× 45 0.6× 33 546
Christian G. Ziegler Germany 16 245 0.9× 89 0.4× 55 0.4× 70 0.8× 199 2.7× 32 847
Petra Popovics United States 16 289 1.1× 92 0.4× 96 0.7× 53 0.6× 51 0.7× 32 715
Kate McNamara United States 9 326 1.3× 156 0.7× 281 2.1× 100 1.1× 121 1.6× 11 850
Stephen MacLennan Italy 15 462 1.8× 87 0.4× 110 0.8× 90 1.0× 107 1.4× 19 1.1k

Countries citing papers authored by Duo Xu

Since Specialization
Citations

This map shows the geographic impact of Duo Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duo Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duo Xu more than expected).

Fields of papers citing papers by Duo Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duo Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duo Xu. The network helps show where Duo Xu may publish in the future.

Co-authorship network of co-authors of Duo Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Duo Xu. A scholar is included among the top collaborators of Duo Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duo Xu. Duo Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Duo, Yanyun Gao, Tong Hu, et al.. (2025). De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma. EMBO Molecular Medicine. 17(9). 2258–2298.
2.
Xu, Juan, Yu Zhu, Peiguo Wang, et al.. (2025). CRISPR/Cas9-Mediated Targeted Mutagenesis of GmAS1/2 Genes Alters Leaf Shape in Soybean. International Journal of Molecular Sciences. 26(19). 9657–9657.
3.
Xu, Duo, Gengyuan Liu, Hongyan Zhao, et al.. (2025). Trade traceability assessment of regional biodiversity loss under multiple environmental pressures. Journal of Cleaner Production. 501. 145284–145284. 2 indexed citations
4.
5.
Xu, Duo, Yanyun Gao, Haitang Yang, et al.. (2024). BAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural Mesothelioma. JTO Clinical and Research Reports. 5(5). 100672–100672. 5 indexed citations
6.
Yeboah, Frederick Kwame, Hui Li, Sai Liang, et al.. (2024). Global supply chain drivers of water use in Sub-Saharan Africa: Taking Ghana as a case. Journal of Cleaner Production. 477. 143844–143844. 2 indexed citations
7.
Liu, Gengyuan, et al.. (2024). Sustainability and resilience interface at typical urban green and blue infrastructures: costs, benefits, and impacts assessment. Frontiers in Sustainable Cities. 6. 2 indexed citations
8.
Zhao, Liang, Jingyi Zhang, Nicola Zamboni, et al.. (2024). Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancer. Cell Death and Differentiation. 32(4). 632–645. 10 indexed citations
9.
Ahmad, Riaz, Gengyuan Liu, Syed Aziz Ur Rehman, et al.. (2024). Pakistan road towards Paris Agreement: Potential decarbonization pathways and future emissions reduction by A developing country. Energy. 314. 134075–134075. 10 indexed citations
10.
Yu, Xinfeng, et al.. (2024). Exploring the Impact of Hemoglobin on Cerebral Blood Flow in Arterial Territories and Surgical Outcomes: Potential Implications for Moyamoya Disease Treatment. Journal of the American Heart Association. 13(19). e035387–e035387. 3 indexed citations
11.
Yang, Haitang, Yanyun Gao, Duo Xu, et al.. (2023). MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma. Cell Death Discovery. 9(1). 55–55. 8 indexed citations
12.
Hu, Junwen, Yongjie Wang, Yun Tong, et al.. (2023). Thalamic structure and anastomosis in different hemispheres of moyamoya disease. Frontiers in Neuroscience. 16. 1058137–1058137.
13.
Xu, Duo, Xi Wu, Thomas M. Marti, et al.. (2022). Dissecting the Immunological Profiles in NSD3-Amplified LUSC through Integrative Multi-Scale Analyses. Cancers. 14(20). 4997–4997. 7 indexed citations
14.
Xu, Duo, et al.. (2022). Early Diagnosis of Murine Sepsis-Associated Encephalopathy Using Dynamic PET/CT Imaging and Multiparametric MRI. Molecular Imaging and Biology. 24(6). 928–939. 7 indexed citations
15.
Zhang, Yang, Shun‐Qing Liang, Haitang Yang, et al.. (2021). CRISPR-Mediated Kinome Editing Prioritizes a Synergistic Combination Therapy for FGFR1 -Amplified Lung Cancer. Cancer Research. 81(11). 3121–3133. 22 indexed citations
16.
Yang, Haitang, Duo Xu, Yang Zhang, et al.. (2020). Systematic Analysis of Aberrant Biochemical Networks and Potential Drug Vulnerabilities Induced by Tumor Suppressor Loss in Malignant Pleural Mesothelioma. Cancers. 12(8). 2310–2310. 14 indexed citations
17.
Xu, Duo, Haitang Yang, Yang Zhang, et al.. (2019). Endoplasmic Reticulum Stress Signaling as a Therapeutic Target in Malignant Pleural Mesothelioma. Cancers. 11(10). 1502–1502. 29 indexed citations
18.
Xu, Duo, Shun‐Qing Liang, Haitang Yang, et al.. (2019). CRISPR Screening Identifies WEE1 as a Combination Target for Standard Chemotherapy in Malignant Pleural Mesothelioma. Molecular Cancer Therapeutics. 19(2). 661–672. 31 indexed citations
19.
Liang, Shun‐Qing, Sabina Berezowska, Thomas M. Marti, et al.. (2018). mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer. Oncogene. 38(5). 622–636. 45 indexed citations
20.
Xu, Duo, Bing Chen, Jianteng Gu, et al.. (2016). Inhibition of autophagy ameliorates pulmonary microvascular dilation and PMVECs excessive proliferation in rat experimental hepatopulmonary syndrome. Scientific Reports. 6(1). 30833–30833. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei Sha Breakdown of academic impact, for papers by Mieke Verslegers Breakdown of academic impact, for papers by Qiqi Xie Breakdown of academic impact, for papers by Lesley Castillo Breakdown of academic impact, for papers by Sonja Kallendrusch Breakdown of academic impact, for papers by Silvia Vanni Breakdown of academic impact, for papers by Christian G. Ziegler Breakdown of academic impact, for papers by Petra Popovics Breakdown of academic impact, for papers by Kate McNamara Breakdown of academic impact, for papers by Stephen MacLennan
Rankless by CCL
2026